http://phys.org/ en-us Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. (AP) -- French drug maker Sanofi-Aventis SA has agreed to buy Genzyme Corp. in a sweetened all-cash $20.1 billion deal that ends months of corporate haggling and positions Sanofi at the forefront of the market in lucrative drugs for rare genetic disorders. http://phys.org/news217051742.html Biology Wed, 16 Feb 2011 04:09:22 EST news217051742 French pharmaceutical giant Sanofi-Aventis said Monday it had extended its bid for US biotechnology group Genzyme without improving an offer that attracted only a fraction of Genzyme shares. http://phys.org/news211452666.html Biology Mon, 13 Dec 2010 09:10:06 EST news211452666 French pharmaceutical giant Sanofi-Aventis said on Wednesday that US competition authorities had not raised any objections to its hostile bid for US biotechnology group and rare disease specialist Genzyme. http://phys.org/news206791808.html Biology Wed, 20 Oct 2010 11:10:21 EST news206791808 (AP) -- France's Sanofi-Aventis on Monday launched an $18.5 billion hostile takeover attempt for Genzyme Corp., escalating the battle after management of the U.S. biotech company twice rejected its offer. http://phys.org/news205413231.html Biology Mon, 04 Oct 2010 12:40:01 EST news205413231 French pharmaceutical group Sanofi-Aventis unveiled Sunday an 18.5 billion dollar (14.5 billion euro) offer for US biotechnology firm Genzyme, hinting it may launch a hostile bid. http://phys.org/news202309709.html Biology Sun, 29 Aug 2010 14:20:01 EST news202309709 (AP) -- Federal health regulators have found tiny particles of trash in drugs made by biotechnology firm Genzyme. http://phys.org/news177342105.html Medicine & Health Fri, 13 Nov 2009 14:10:03 EST news177342105